Oslo, 9 March 2024: Langøya Invest AS, a closely related party of Ketil
Fjerdingen, a board member and primary insider in Ultimovacs ASA, sold on 8
March 2024, 400,000 shares in the company at an average price of NOK 7.8984 per
share. Following these transactions, Langøya Invest AS and closely related
parties hold 400,000 shares in Ultimovacs ASA.

This information is subject to the disclosure requirements pursuant to the
Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities
Trading Act.